Idiopathic noncirrhotic portal hypertension is associated with poor survival: Results of a long-term cohort study

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 12, 2012, Pages 1424-1433

  Schouten, J N L ^a   Nevens, F ^b   Hansen, B ^a   Laleman, W ^b   Van Den Born, M ^a   Komuta, M ^b   Roskams, T ^b   Verheij, J ^c   Janssen, H L A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE;

ADULT; AGE DISTRIBUTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASCITES; CLINICAL FEATURE; COHORT ANALYSIS; DECOMPENSATED LIVER CIRRHOSIS; ENDOSCOPIC THERAPY; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HEPATOPULMONARY SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IDIOPATHIC NONCIRRHOTIC PORTAL HYPERTENSION; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VARIX BLEEDING; VEIN DISEASE;

ADULT; AGE FACTORS; ASCITES; BELGIUM; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PORTAL; KAPLAN-MEIER ESTIMATE; LIVER DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; PROGNOSIS; SURVIVAL RATE; TIME FACTORS;

EID: 84861202740     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05112.x     Document Type: Article

References (29)

1. Sanyal AJ, Bosch J, Blei A, Arroyo V,. Portal hypertension and its complications. Gastroenterology 2008; 134: 1715-28. (Pubitemid 351626956)
2. Schouten JN, Garcia-Pagan JC, Valla DC, Janssen HL,. Idiopathic noncirrhotic portal hypertension. Hepatology 2011; 54: 1071-81.
3. Sarin SK, Kapoor D,. Non-cirrhotic portal fibrosis: current concepts and management. J Gastroenterol Hepatol 2002; 17: 526-34. (Pubitemid 34748172)
4. Hillaire S, Bonte E, Denninger MH, et al,. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 2002; 51: 275-80. (Pubitemid 34791461)
5. Nevens F, Staessen D, Sciot R, et al,. Clinical aspects of incomplete septal cirrhosis in comparison with macronodular cirrhosis. Gastroenterology 1994; 106: 459-63. (Pubitemid 24041224)
6. Inagaki H, Nonami T, Kawagoe T, et al,. Idiopathic portal hypertension associated with systemic lupus erythematosus. J Gastroenterol 2000; 35: 235-9. (Pubitemid 30195637)
7. Feld JJ, Hussain N, Wright EC, et al,. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Gastroenterology 2008; 134: 1917-26. (Pubitemid 351783257)
8. Eckel RH, Grundy SM, Zimmet PZ,. The metabolic syndrome. Lancet 2005; 365: 1415-28. (Pubitemid 40523737)
9. Wanless IR,. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11: 787-97. (Pubitemid 20191384)
10. Ohbu M, Okudaira M, Watanabe K, Kaneko S, Takai T,. Histopathological study of intrahepatic aberrant vessels in cases of noncirrhotic portal hypertension. Hepatology 1994; 20: 302-8. (Pubitemid 24233353)
11. Sciot R, Staessen D, Van Damme B, et al,. Incomplete septal cirrhosis: histopathological aspects. Histopathology 1988; 13: 593-603. (Pubitemid 19038604)
12. Eapen CE, Nightingale P, Hubscher SG, et al,. Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors. Dig Dis Sci 2011; 56: 227-35.
13. Cazals-Hatem D, Hillaire S, Rudler M, et al,. Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J Hepatol 2011; 141: 1024-35.
14. Kono K, Ohnishi K, Omata M, et al,. Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits. Gastroenterology 1988; 94: 787-96. (Pubitemid 18073544)
15. Mallet VO, Varthaman A, Lasne D, et al,. Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients. AIDS 2009; 23: 1511-8.
16. Krasinskas AM, Eghtesad B, Kamath PS, Demetris AJ, Abraham SC,. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl 2005; 11: 627-34. (Pubitemid 40872900)
17. Chang PE, Miquel R, Blanco JL, et al,. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am J Gastroenterol 2009; 104: 1707-14.
18. Tsuneyama K, Ohba K, Zen Y, et al,. A comparative histological and morphometric study of vascular changes in idiopathic portal hypertension and alcoholic fibrosis/cirrhosis. Histopathology 2003; 43: 55-61. (Pubitemid 36836588)
19. Okuda K, Kono K, Ohnishi K, et al,. Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology 1984; 86: 600-10. (Pubitemid 14164710)
20. Stromeyer FW, Ishak KG,. Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol 1981; 12: 60-71. (Pubitemid 12239395)
21. Colina F, Alberti N, Solis JA, Martinez-Tello FJ,. Diffuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathologic study of 24 cases. Liver 1989; 9: 253-65. (Pubitemid 19249669)
22. Moucari R, Rautou PE, Cazals-Hatem D, et al,. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors. Gut 2008; 57: 828-35. (Pubitemid 351716980)
23. Vernier-Massouille G, Cosnes J, Lemann M, et al,. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut 2007; 56: 1404-9. (Pubitemid 47517834)
24. Sarin SK, Kumar A, Chawla YK, et al,. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int 2007; 1: 398-413.
25. Spaander MC, Darwish Murad S, van Buuren HR, Hansen BE, Kuipers EJ, Janssen HL,. Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study. Gastrointest Endosc 2008; 67: 821-7.
26. Dumortier J, Bizollon T, Scoazec JY, et al,. Orthotopic liver transplantation for idiopathic portal hypertension: indications and outcome. Scand J Gastroenterol 2001; 36: 417-22. (Pubitemid 32250739)
27. Loinaz C, Colina F, Musella M, et al,. Orthotopic liver transplantation in 4 patients with portal hypertension and non-cirrhotic nodular liver. Hepatogastroenterology 1998; 45: 1787-94. (Pubitemid 28515203)
28. Janssen HL, Wijnhoud A, Haagsma EB, et al,. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001; 49: 720-4. (Pubitemid 32989212)
29. Merkel C, Bolognesi M, Bellon S, et al,. Long-term follow-up study of adult patients with non-cirrhotic obstruction of the portal system: comparison with cirrhotic patients. J Hepatol 1992; 15: 299-303.